You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

entrectinib

Showing 1 - 25 of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveal Melanoma Trial in Minneapolis (PAC-1, Entrectinib)

Active, not recruiting
  • Uveal Melanoma
  • Minneapolis, Minnesota
    HealthPartners Institute Regions Cancer Care Center
Nov 15, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 25, 2022

Hepatic Insufficiency Trial in Praha 7, Miskolc, Bratislava (entrectinib)

Completed
  • Hepatic Insufficiency
  • entrectinib
  • Praha 7, Czechia
  • +2 more
Jan 14, 2022

Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Oslo, Norway
    Pfizer Norway
Apr 17, 2023

Solid Tumor, Haematological Malignancy, Malignancy Trial in United Kingdom (Entrectinib)

Recruiting
  • Solid Tumor
  • +10 more
  • Entrectinib
  • Belfast, United Kingdom
  • +25 more
Mar 14, 2023

Invasive Lobular Breast Carcinoma, ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Belgium, France (Entrectinib,

Recruiting
  • Invasive Lobular Breast Carcinoma
  • +2 more
  • Entrectinib
  • +2 more
  • Brussels, Belgium
  • +9 more
May 4, 2022

Solid Tumor Trial in Nottingham (Entrectinib 600 mg (T1), Entrectinib 600 mg (T2), Entrectinib 200 mg (R))

Completed
Has Results
  • Solid Tumor
  • Entrectinib 600 mg (T1)
  • +3 more
  • Nottingham, United Kingdom
    Quotient Clinical Ltd, Clinical Research Unit
Sep 4, 2020

NSCLC Trial in Worldwide (Entrectinib, Crizotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Barretos, SP, Brazil
  • +66 more
Jan 27, 2023

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

Recruiting
  • Solid Tumors
  • CNS Tumors
  • Entrectinib
  • Orange, California
  • +38 more
Aug 24, 2022

NSCLC Trial in Worldwide (Alectinib, Entrectinib, Pralsetinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • San José, Costa Rica
  • +3 more
Aug 4, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Korea, Republic of, United States (Entrectinib)

Completed
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Entrectinib
  • Orange, California
  • +9 more
Jun 7, 2021

Cancer Metastatic Trial in Norway (Atezolizumab)

Recruiting
  • Cancer Metastatic
  • Bergen, Norway
  • +16 more
Oct 24, 2022

Soft Tissue Sarcoma Adult Trial in Lake Success, Portland, Seattle (Multiple drug microinjection, CIVO device)

Completed
  • Soft Tissue Sarcoma Adult
  • Multiple drug microinjection
  • CIVO device
  • Lake Success, New York
  • +2 more
Sep 22, 2021

Healthy Volunteers Trial in Dallas (Entrectinib Form A, Entrectinib Form C)

Completed
Has Results
  • Healthy Volunteers
  • Entrectinib Form A
  • Entrectinib Form C
  • Dallas, Texas
    Covance Research Unit - Dallas
Feb 25, 2020

Healthy Volunteers Trial in Daytona Beach (Entrectinib Test Formulation (F1), Entrectinib Reference Formulation (F06))

Completed
Has Results
  • Healthy Volunteers
  • Entrectinib Test Formulation (F1)
  • Entrectinib Reference Formulation (F06)
  • Daytona Beach, Florida
    Covance Research Unit - Daytona
Feb 25, 2020

NSCLC Trial in United States (Alectinib, Entrectinib, Vemurafenib)

Recruiting
  • Non-small Cell Lung Cancer
  • Duarte, California
  • +24 more
Feb 2, 2023

Breast Cancer, Gastrointestinal Cancer, Non Small Cell Lung Cancer Trial in Italy (Erlotinib, Trastuzumab, Trastuzumab

Recruiting
  • Breast Cancer
  • +3 more
  • Ancona, Italy
  • +40 more
Jan 25, 2023

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Entrectinib
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)

Recruiting
  • Solid Tumor
  • Haematological Malignancy
  • Belfast, United Kingdom
  • +24 more
Jan 31, 2023

ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

Terminated
Has Results
  • ALK Fusion Protein Expression
  • +14 more
  • San Francisco, California
    University of California, San Francisco
Jan 14, 2020

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer Trial in France (Blood and tumor samples)

Recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • Blood and tumor samples
  • Clermont-Ferrand, France
  • +9 more
Dec 8, 2021

Solid Tumors Trial in Worldwide (Entrectinib, Alectinib, Atezolizumab)

Recruiting
  • Solid Tumors
  • Entrectinib
  • +8 more
  • Daphne, Alabama
  • +156 more
Jan 13, 2023

Cancers With NTRK, ROS1, or ALK Gene Fusions Trial in San Diego (Entrectinib)

No longer available
  • Cancers With NTRK, ROS1, or ALK Gene Fusions
  • Entrectinib
  • San Diego, California
    1-844-Startrk (782-7875)
Apr 24, 2019